| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Ayer Capital Management, LP last filed a Form 4 in May 2015, as 10% Owner at IOVA.
At the last filing, the largest reported position was 2,823,333 shares of IOVA. The IOVA filings lean toward selling, a net 2,780,682 shares.
Ayer Capital Management, LP has 1 Form 4 filing on record in May 2015, as 10% Owner at Iovance Biotherapeutics (IOVA), 2015.
The 1 reported transaction was 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $26.8M.
The only open-market sale was 2,780,682 shares of IOVA at an average $9.62 on May 1, 2015, about $26.8M.
Shares as reported in the last Form 4 for each company; the most recent is from May 2015. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 1, 2015 | IOVA Iovance Biotherapeutics, Inc. | 10% Owner | Sell | 2,780,682 | $9.62 | $26,752,385.39 | -49.6% |